6-151808318-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_000125.4(ESR1):c.406C>T(p.Pro136Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000215 in 1,558,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_000125.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ESR1 | NM_000125.4 | c.406C>T | p.Pro136Ser | missense_variant | 1/8 | ENST00000206249.8 | NP_000116.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ESR1 | ENST00000206249.8 | c.406C>T | p.Pro136Ser | missense_variant | 1/8 | 1 | NM_000125.4 | ENSP00000206249 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000961 AC: 146AN: 151982Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000243 AC: 43AN: 177238Hom.: 0 AF XY: 0.000205 AC XY: 20AN XY: 97336
GnomAD4 exome AF: 0.000134 AC: 189AN: 1406734Hom.: 0 Cov.: 36 AF XY: 0.000111 AC XY: 77AN XY: 694418
GnomAD4 genome AF: 0.000960 AC: 146AN: 152100Hom.: 0 Cov.: 32 AF XY: 0.000847 AC XY: 63AN XY: 74376
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The ESR1 p.Pro136Ser variant was not identified in the literature nor was it identified in ClinVar, Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs201145204) and in control databases in 72 of 208534 chromosomes at a frequency of 0.000345 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 71 of 19540 chromosomes (freq: 0.003634) and Latino in 1 of 28696 chromosomes (freq: 0.000035), but was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), European (non-Finnish), Other or South Asian populations. The p.Pro136 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at